EIAV-based retinal gene therapy in the shaker1 mouse model for usher syndrome type 1B: development of UshStat. - Wikidata - wikimedia - TriplyDB

EIAV-based retinal gene therapy in the shaker1 mouse model for usher syndrome type 1B: development of UshStat.

EIAV-based retinal gene therapy in the shaker1 mouse model for usher syndrome type 1B: development of UshStat.

http://www.wikidata.org/entity/Q35140281

about

Promising and delivering gene therapies for vision loss Gene therapy of inherited retinal degenerations: prospects and challenges Advancing therapeutic strategies for inherited retinal degeneration: recommendations from the Monaciano Symposium What Is Next for Retinal Gene Therapy?Usher syndrome: Hearing loss, retinal degeneration and associated abnormalities.CLINICAL PROGRESS IN INHERITED RETINAL DEGENERATIONS: GENE THERAPY CLINICAL TRIALS AND ADVANCES IN GENETIC SEQUENCING.Vector platforms for gene therapy of inherited retinopathies.Photoreceptors in whirler mice show defective transducin translocation and are susceptible to short-term light/dark changes-induced degeneration.Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A Retinal Gene Therapy: Current Progress and Future Prospects.Non-viral therapeutic approaches to ocular diseases: An overview and future directions Advances in Gene Therapy for Diseases of the Eye.Lentiviral Vector Gene Transfer of Endostatin/Angiostatin for Macular Degeneration (GEM) Study.Correction of Monogenic and Common Retinal Disorders with Gene Therapy.Gene and cell-based therapies for inherited retinal disorders: An update.Hereditary Retinal Dystrophy.Whole USH2A Gene Sequencing Identifies Several New Deep Intronic Mutations.Electroretinography Reveals Difference in Cone Function between Syndromic and Nonsyndromic USH2A Patients.Genome Surgery and Gene Therapy in Retinal Disorders.Gene therapy and genome surgery in the retina.Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.Non-Primate Lentiviral Vectors and Their Applications in Gene Therapy for Ocular Disorders.Gene editing in the context of an increasingly complex genome

P2860

Q27007079-1D1C6185-0E19-408B-83C2-FEEAD553FEAF Q27009261-71BF525B-3792-4E94-99DB-332396ED5995 Q27694625-F8EAB264-5209-4EA3-8A67-D11EF6937AAB Q28082800-BC300649-0ACE-44D1-8B62-3EEF87D6A87F Q30389509-9D84ACB6-4CF6-4262-AA23-1B7EB09D2993 Q33782257-AA22CEEE-5EB9-4692-AF1E-686EACE13306 Q34561531-0E04A0DA-52A3-4F07-B1E7-00D1E71D4B9E Q35534861-AC1CE59D-0FD6-47E3-B10D-3DE1A291B943 Q35664199-B0C7204D-BD95-4978-94D4-BE8C192E91EF Q36306263-8D35130C-8294-40C1-96E3-6E5855C43F1A Q36425890-7692B3CB-1B94-4A31-A9BB-6151B157E703 Q37190609-92F2F9CC-8BE3-4973-B073-E708D3F340F0 Q37613100-6D9A820A-80E7-48E4-A4A1-6599A9A307E6 Q37676230-E2C669AE-D2E0-48C6-95C0-DBC00B57A0C2 Q39013159-6C45A924-545F-4139-836B-76A0A0F7804C Q39051446-8F38635E-91E5-45AB-838D-60D7B66FBE55 Q40249950-32DA5A13-0E79-476F-B285-4D86332AFD40 Q41328140-68AD7D7D-7F0F-4778-A45C-39AEC59E537A Q52429662-72FFA496-E737-4685-854D-E049EA7D57DC Q54977409-ED9103CE-F1D0-4BEE-80B9-BA20C6AA8A7F Q55000684-65DCC76B-2CA1-450D-B47B-61EEE09FCE27 Q55641400-49858CE3-D8F3-4760-8778-B32DCDC11662 Q57170220-B90F7317-2102-491B-BCBC-B52E4A26547E

P2860

EIAV-based retinal gene therapy in the shaker1 mouse model for usher syndrome type 1B: development of UshStat.

http://www.wikidata.org/entity/Q35140281

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

EIAV-based retinal gene therap ...... pe 1B: development of UshStat.

@ast

EIAV-based retinal gene therap ...... pe 1B: development of UshStat.

@en

type

label

EIAV-based retinal gene therap ...... pe 1B: development of UshStat.

@ast

EIAV-based retinal gene therap ...... pe 1B: development of UshStat.

@en

prefLabel

EIAV-based retinal gene therap ...... pe 1B: development of UshStat.

@ast

EIAV-based retinal gene therap ...... pe 1B: development of UshStat.

@en

P1433

Q35140281-F6049C48-7A18-4EF4-8625-77C116698BAD

P1476

Q35140281-D6232F3F-D10B-48F0-82DA-0DDCCF0FD676

P2093

Q35140281-2B9857CA-508C-4DA4-9CE5-1603A385FF4D

Q35140281-2D5EA129-0A6E-4599-B813-28D456789176

Q35140281-3420A01E-83FB-4361-B8F3-6C87F838DC68

Q35140281-3C4DC921-C2FA-4974-B450-86EF19C1DAB8

Q35140281-3CF0287F-01CC-4D60-ACFB-509DE7057D9F

Q35140281-52DDD678-80E7-4D8C-86EF-3FEAC8F18CD4

Q35140281-54E5887A-6598-4B16-AE70-7DC0D5C6ECC9

Q35140281-5BECB702-E885-4444-8149-B640AAC827B0

Q35140281-88384664-9620-475E-8D2D-67638213EA4A

Q35140281-8A639F5D-D87E-4BCF-91BA-57B876B2CE10

P2860

Q35140281-0562EE4F-DB72-445F-AA07-DD8A193D4A81

Q35140281-13244E2A-6607-4C3A-93AE-EFA848E2C8D4

Q35140281-1810C818-B2FD-4518-AB34-A4EAA07CB20E

Q35140281-1D9541EA-8189-4892-83F6-B145F72ABCCA

Q35140281-26405D5D-C53F-4DAF-A7FA-E640153C7B41

Q35140281-28111E6E-9C73-48AF-BCEF-C732C5227A3E

Q35140281-2B2426F1-C337-4A26-91B0-E5D4DDE4225F

Q35140281-3A1CF2EA-DC48-4F5C-B616-5EB33F2F9FC8

Q35140281-3D4F62B2-8A3E-4005-9CB5-F2BC773539E1

Q35140281-3F1DA934-5107-411A-B390-8FC6462AB055

P304

Q35140281-93EE88F3-ACD6-46C1-BF82-58F2343CE1EE

P31

Q35140281-8747F36E-F089-4E3F-BC5D-1AE1A2F9B6EA

P356

Q35140281-197531F4-0FDA-45E5-AD7B-2668D27EC3DE

P407

Q35140281-DD759BAF-20E2-4B17-A33D-879B8C77A8F0

P433

Q35140281-CBAEF449-9CF6-44E0-9725-4E2E5AF411DD

P478

Q35140281-DD5D15CA-8136-4E9B-85E7-1D1C4E43D858

P577

Q35140281-5D9BD73B-F00D-4BE0-80B5-CBEF12164DA8

P5875

Q35140281-5A0413C7-7E16-44BE-9399-FA19EBE8CA97

P698

Q35140281-A03CE87E-2018-4804-9839-3F825C5187CE

P921

Q35140281-FE231EEE-5171-4907-A601-C983552061CE

P932

Q35140281-6FF39ACC-0D82-4F83-B87E-5C8A29B48F9F

P356

JOURNAL.PONE.0094272

P1433

P1476

EIAV-based retinal gene therap ...... pe 1B: development of UshStat.

@en

P2093

Dominic Cosgrove

http://www.w3.org/2001/XMLSchema#string

Duane Delimont

http://www.w3.org/2001/XMLSchema#string

James Miskin

http://www.w3.org/2001/XMLSchema#string

Julie Loader

http://www.w3.org/2001/XMLSchema#string

Katie Binley

http://www.w3.org/2001/XMLSchema#string

Kyriacos A Mitrophanous

http://www.w3.org/2001/XMLSchema#string

Linda Cheung

http://www.w3.org/2001/XMLSchema#string

Marisa Zallocchi

http://www.w3.org/2001/XMLSchema#string

Michelle Kelleher

http://www.w3.org/2001/XMLSchema#string

Peter Widdowson

http://www.w3.org/2001/XMLSchema#string

P2860

A defect in harmonin, a PDZ domain-containing protein expressed in the inner ear sensory hair cells, underlies Usher syndrome type 1C

Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D

Mutations of the protocadherin gene PCDH15 cause Usher syndrome type 1F

Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin

Alterations of the CIB2 calcium- and integrin-binding protein cause Usher syndrome type 1J and nonsyndromic deafness DFNB48.

Mutations in the VLGR1 gene implicate G-protein signaling in the pathogenesis of Usher syndrome type II

The unconventional myosin-VIIa associates with lysosomes

Defective myosin VIIA gene responsible for Usher syndrome type 1B

Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23

Usher syndrome type III: revised genomic structure of the USH3 gene and identification of novel mutations

P304

e94272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0094272

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261408537

http://www.w3.org/2001/XMLSchema#string

P698

24705452

http://www.w3.org/2001/XMLSchema#string

P921

P932

3976400

http://www.w3.org/2001/XMLSchema#string